It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Active telomerase is essential for stem cells and most cancers to maintain telomeres. The enzymatic activity of telomerase is related but not equivalent to the expression of TERT, the catalytic subunit of the complex. Here we show that telomerase enzymatic activity can be robustly estimated from the expression of a 13-gene signature. We demonstrate the validity of the expression-based approach, named EXTEND, using cell lines, cancer samples, and non-neoplastic samples. When applied to over 9,000 tumors and single cells, we find a strong correlation between telomerase activity and cancer stemness. This correlation is largely driven by a small population of proliferating cancer cells that exhibits both high telomerase activity and cancer stemness. This study establishes a computational framework for quantifying telomerase enzymatic activity and provides new insights into the relationships among telomerase, cancer proliferation, and stemness.
Telomerase activity correlates with distinct cell states, but can be challenging to quantify. Here the authors quantify telomerase activity across a range of biological samples using the expression of 13 genes, and show it correlates with cancer cell proliferation and stemness.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details


1 UT Health San Antonio, Greehey Children’s Cancer Research Institute, San Antonio, USA; UT Health San Antonio, Department of Population Health Sciences, San Antonio, USA
2 MD Anderson Cancer Center, Department of Neuro-Oncology, Houston, USA (GRID:grid.240145.6) (ISNI:0000 0001 2291 4776)
3 UT Health San Antonio, Greehey Children’s Cancer Research Institute, San Antonio, USA (GRID:grid.240145.6)
4 UT Health San Antonio, Department of Population Health Sciences, San Antonio, USA (GRID:grid.240145.6)
5 UT Health San Antonio, Greehey Children’s Cancer Research Institute, San Antonio, USA (GRID:grid.240145.6); UT Health San Antonio, Department of Population Health Sciences, San Antonio, USA (GRID:grid.240145.6)
6 University of Michigan, Department of Movement Science, Ann Arbor, USA (GRID:grid.214458.e) (ISNI:0000000086837370)
7 UT Health San Antonio, Greehey Children’s Cancer Research Institute, San Antonio, USA (GRID:grid.214458.e); UT Health San Antonio, Department of Population Health Sciences, San Antonio, USA (GRID:grid.214458.e)